These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 6996443)

  • 21. Comparison of putative dopamine receptors in blood vessels and the central nervous system.
    Goldberg LI
    Adv Neurol; 1975; 9():53-6. PubMed ID: 238377
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of haloperidol and chlorpromazine on central adrenergic and cholinergic mechanisms in rabbits.
    Consroe PF; White RP
    Arch Int Pharmacodyn Ther; 1972; 198(1):67-75. PubMed ID: 5053242
    [No Abstract]   [Full Text] [Related]  

  • 23. [Psychopharmacological analysis of the action of chlorpromazine, haloperidol and pentobarbital in simultaneous double conditioning].
    Molinengo L; Ricci-Galamero S
    Boll Soc Ital Biol Sper; 1971 Jul; 47(13):388-92. PubMed ID: 5133290
    [No Abstract]   [Full Text] [Related]  

  • 24. Neuroleptic-induced changes in the anxiolytic and myorelaxant properties of diazepam in the rat.
    Taukulis HK; Fillmore MT; Ruggles JL
    Pharmacol Biochem Behav; 1992 Jan; 41(1):13-21. PubMed ID: 1347171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of chlorpromazine and haloperidol on the disposition of mescaline-14C in mice.
    Shah NS; Shah KR; Lawrence RS; Neely AE
    J Pharmacol Exp Ther; 1973 Aug; 186(2):297-304. PubMed ID: 4719782
    [No Abstract]   [Full Text] [Related]  

  • 26. [The effect of aminazine and tofranil on behavioral reactions during electrostimulation of the subcortical structures of the cat brain].
    Levtova FA; Slezin VB
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1968; 18(2):272-9. PubMed ID: 5741464
    [No Abstract]   [Full Text] [Related]  

  • 27. Increased irritability: a permanent behavior change induced in the rat by intraventricular administration of 6-hydroxydopamine.
    Nakamura K; Thoenen H
    Psychopharmacologia; 1972; 24(3):359-72. PubMed ID: 5034938
    [No Abstract]   [Full Text] [Related]  

  • 28. [Cloxazepine: neuropharmacological studies].
    Stefanova D
    Eksp Med Morfol; 1981; 20(4):208-13. PubMed ID: 7327147
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effects of psychotropic drugs on exploratory behavior of mice (author's transl)].
    Minck K; Danneberg P; Knappen F
    Psychopharmacologia; 1974; 39(3):245-57. PubMed ID: 4427991
    [No Abstract]   [Full Text] [Related]  

  • 30. Behavioral and neurochemical studies of opioid effects in the pedunculopontine nucleus and mediodorsal thalamus.
    Klitenick MA; Kalivas PW
    J Pharmacol Exp Ther; 1994 Apr; 269(1):437-48. PubMed ID: 8169850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of biogenic amines in the extra-pyramidal system.
    Ernst AM
    Acta Physiol Pharmacol Neerl; 1969 Jun; 15(2):141-54. PubMed ID: 5799067
    [No Abstract]   [Full Text] [Related]  

  • 32. Evidence for a role for dopamine in the diazepam locomotor stimulating effect.
    Söderpalm B; Svensson L; Hulthe P; Johannessen K; Engel JA
    Psychopharmacology (Berl); 1991; 104(1):97-102. PubMed ID: 1679244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapid development of hypersensitivity and hyposensitivity to apomorphine and haloperidol: role of norepinephrine receptor mechanisms in CNS.
    Cools AR
    Adv Biochem Psychopharmacol; 1980; 24():215-22. PubMed ID: 6996442
    [No Abstract]   [Full Text] [Related]  

  • 34. The influence of psychotropic drugs on the animal EEG: electrophysiological analysis of the effects of psychotropic drugs.
    Yamaguchi N; Yoshimoto H; Kubota M; Ito T; Nakamura K
    Electroencephalogr Clin Neurophysiol Suppl; 1982; 36():566-76. PubMed ID: 6962043
    [No Abstract]   [Full Text] [Related]  

  • 35. The dopamine-releasing actions of neuroleptics and ethanol.
    Seeman P; Lee T
    J Pharmacol Exp Ther; 1974 Jul; 190(1):131-40. PubMed ID: 4847309
    [No Abstract]   [Full Text] [Related]  

  • 36. Possible anti-oxidant and neuroprotective mechanisms of zolpidem in attenuating typical anti-psychotic-induced orofacial dyskinesia: a biochemical and neurochemical study.
    Bishnoi M; Chopra K; Kulkarni SK
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1130-8. PubMed ID: 17513028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroleptic action of quaternary chlorpromazine and related drugs injected into various brain areas in rats.
    Fog RL; Randrup A; Pakkenberg H
    Psychopharmacologia; 1968; 12(5):428-32. PubMed ID: 5749325
    [No Abstract]   [Full Text] [Related]  

  • 38. The influence of antineoplaston A5 on the central dopaminergic structures.
    Juszkiewicz M; Chodkowska A; Burzynski SR; Feldo M; Majewska B; Kleinrok Z
    Drugs Exp Clin Res; 1994; 20(4):161-7. PubMed ID: 7813388
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Socioactography. A method for quantification of contact behaviour and motor activity of rats in a group and its use in psychopharmacology.
    Tikal K; Benesová O
    Act Nerv Super (Praha); 1972 Nov; 14(4):273-9. PubMed ID: 5083829
    [No Abstract]   [Full Text] [Related]  

  • 40. Involvement of nitric oxide (NO) signaling pathway in the antidepressant action of bupropion, a dopamine reuptake inhibitor.
    Dhir A; Kulkarni SK
    Eur J Pharmacol; 2007 Jul; 568(1-3):177-85. PubMed ID: 17509558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.